Literature DB >> 21898417

B lymphocytes as effector cells in the immunotherapy of cancer.

Jukes P Namm1, Qiao Li, Xiangming Lao, David M Lubman, Jintang He, Yashu Liu, Jianhui Zhu, Shuang Wei, Alfred E Chang.   

Abstract

Over the years, the role of B cells in the host immune response to malignancy has been overshadowed by our focus on T cells. Nevertheless, B cells play important roles as antigen-presenting cells and in the production of antibodies. Furthermore, B cells can function as effector cells that mediate tumor destruction on their own. This review will highlight the various functions of B cells that are involved in the host response to tumor.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2011        PMID： 21898417      PMCID： PMC4315332          DOI： 10.1002/jso.22093

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  42 in total

1.  B cell-dependent TCR diversification.

Authors:  Cristina João; Brenda M Ogle; Carlota Gay-Rabinstein; Jeffrey L Platt; Marilia Cascalho
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

Review 2.  A case for regulatory B cells.

Authors:  Atsushi Mizoguchi; Atul K Bhan
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

3.  The B cell is the initiating antigen-presenting cell in peripheral lymph nodes.

Authors:  C A Janeway; J Ron; M E Katz
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

4.  Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression.

Authors:  Qiao Li; Xiangming Lao; Qin Pan; Ning Ning; Ji Yet; Yingxin Xu; Shengping Li; Alfred E Chang
Journal:  Clin Cancer Res       Date:  2011-06-20       Impact factor: 12.531

5.  Characterization of a novel human tumor antigen interleukin-13 receptor alpha2 chain.

Authors:  Koji Kawakami; Masaki Terabe; Mariko Kawakami; Jay A Berzofsky; Raj K Puri
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

6.  CD4+ and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells.

Authors:  P A Monach; H Schreiber; D A Rowley
Journal:  Transplantation       Date:  1993-06       Impact factor: 4.939

Review 7.  The 'short' history of regulatory B cells.

Authors:  Claudia Mauri; Michael R Ehrenstein
Journal:  Trends Immunol       Date:  2007-12-03       Impact factor: 16.687

8.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

Review 9.  Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency.

Authors:  C Bacchelli; S Buckridge; A J Thrasher; H B Gaspar
Journal:  Clin Exp Immunol       Date:  2007-09       Impact factor: 4.330

10.  The functions of the thymus system and the bursa system in the chicken.

Authors:  M D Cooper; D A Raymond; R D Peterson; M A South; R A Good
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307
View more
  10 in total

1.  Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.

Authors:  Louis T Curtis; Susanne Sebens; Hermann B Frieboes
Journal:  Cancer Immunol Immunother       Date:  2020-11-12       Impact factor: 6.968

2.  Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival.

Authors:  Caroline M Reed; Nicole D Cresce; Ileana S Mauldin; Craig L Slingluff; Walter C Olson
Journal:  Clin Cancer Res       Date:  2015-05-12       Impact factor: 12.531

3.  A comprehensive analysis of TDO2 expression in immune cells and characterization of immune cell phenotype in TDO2 knockout mice.

Authors:  Susu Li; Siyu Li; Yingjie Zhao; Bingjie Zhang; Xinwei Wang; Xuezhi Yang; Yueye Wang; Chengyan Jia; Yan Chang; Wei Wei
Journal:  Transgenic Res       Date:  2021-09-16       Impact factor: 2.788

4.  The thyroid status reprograms T cell lymphoma growth and modulates immune cell frequencies.

Authors:  H A Sterle; M L Barreiro Arcos; E Valli; M A Paulazo; S P Méndez Huergo; A G Blidner; F Cayrol; M C Díaz Flaqué; A J Klecha; V A Medina; L Colombo; G A Rabinovich; G A Cremaschi
Journal:  J Mol Med (Berl)       Date:  2015-11-13       Impact factor: 4.599

5.  Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.

Authors:  Simone Punt; Willem E Corver; Sander A J van der Zeeuw; Szymon M Kielbasa; Elisabeth M Osse; Henk P J Buermans; Cornelis D de Kroon; Ekaterina S Jordanova; Arko Gorter
Journal:  Oncotarget       Date:  2015-11-17

6.  CP-25, a Novel Anti-inflammatory and Immunomodulatory Drug, Inhibits the Functions of Activated Human B Cells through Regulating BAFF and TNF-alpha Signaling and Comparative Efficacy with Biological Agents.

Authors:  Feng Zhang; Jin-Ling Shu; Ying Li; Yu-Jing Wu; Xian-Zheng Zhang; Le Han; Xiao-Yu Tang; Chen Wang; Qing-Tong Wang; Jing-Yu Chen; Yan Chang; Hua-Xun Wu; Ling-Ling Zhang; Wei Wei
Journal:  Front Pharmacol       Date:  2017-12-22       Impact factor: 5.810

7.  Pancreatic adenocarcinomas with mature blood vessels have better overall survival.

Authors:  Eriko Katsuta; Qianya Qi; Xuan Peng; Steven N Hochwald; Li Yan; Kazuaki Takabe
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

Review 8.  Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity.

Authors:  You Qin; Furong Lu; Kexing Lyu; Alfred E Chang; Qiao Li
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

Review 9.  Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis.

Authors:  You Qin; Fei Peng; Lisha Ai; Shidai Mu; Yuting Li; Chensu Yang; Yu Hu
Journal:  Cancer Cell Int       Date:  2021-06-12       Impact factor: 5.722

10.  GIFT4 fusokine converts leukemic B cells into immune helper cells.

Authors:  Jiusheng Deng; Andrea Pennati; Jonathon B Cohen; Yuanqiang Wu; Spencer Ng; Jian Hui Wu; Christopher R Flowers; Jacques Galipeau
Journal:  J Transl Med       Date:  2016-04-27       Impact factor: 5.531
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.